Stock Research: Boryung Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Boryung Pharmaceutical

KOSE:A003850 KR7003850005
69
  • Value
    54
  • Growth
    46
  • Safety
    Safety
    57
  • Combined
    53
  • Sentiment
    76
  • 360° View
    360° View
    69
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based pharmaceutical company that manufactures and sells various pharmaceutical products. The company operates in the pharmaceutical industry, producing and distributing drugs such as antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, and anticancer drugs. It distributes its products in domestic and overseas markets. In the last fiscal year, the company had a market cap of $524 million, profits of $246 million, and revenue of $689 million. The number of employees is not available.

more
Index
KOSPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 52 48 37
Growth
46 51 83 41
Safety
Safety
57 30 28 28
Sentiment
76 90 92 75
360° View
360° View
69 86 75 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
100 100 100 87
Opinions Change
50 50 50 18
Pro Holdings
n/a 50 56 82
Market Pulse
80 72 80 n/a
Sentiment
76 90 92 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
54 52 48 37
Growth
46 51 83 41
Safety Safety
57 30 28 28
Combined
53 51 48 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
52 63 44 40
Price vs. Earnings (P/E)
84 80 85 65
Price vs. Book (P/B)
64 48 42 35
Dividend Yield
35 32 35 36
Value
54 52 48 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
78 54 72 55
Profit Growth
84 13 41 64
Capital Growth
20 98 95 49
Stock Returns
26 38 57 23
Growth
46 51 83 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
41 37 27 16
Refinancing
84 46 59 69
Liquidity
30 60 34 34
Safety Safety
57 30 28 28

Similar Stocks

Discover high‑ranked alternatives to Boryung Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

KT

KOSE:A030200
Country: South Korea
Industry: Integrated Telecommunication
Size: Large
Full Stock Analysis

NH Investment & Securities

KOSE:A005940
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Medium
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: